Home All news

Mitsui makes a strategic investment in supplements and blood testing specialist Thorne

Thorne Research supplements

Thorne, a nutritional supplements partner to USA Triathlon along with other national governing bodies, has confirmed that Mitsui, one of Japan’s largest trading companies and part of the Mitsui Group, has made a strategic investment in Thorne, with the purpose of expanding business in the United States and Japan.

After a thorough review of Thorne’s business platform, Mitsui decided to expand its wellness business in Japan, utilizing Thorne’s nutritional supplement products and diagnostic testing platforms. Mitsui plans to launch collaborations with other Japanese companies for wellness product development and distribution, and joins the Helsinn Group as the second international strategic investor in Thorne.

“We are proud to partner with Mitsui because Mitsui is a great cultural fit for us due to their strong appreciation for science and research,” said Paul Jacobson, Thorne’s CEO. “By tapping into Mitsui’s US$40 billion annual sales network, we will be able to expand our strategic relationships in ways we could not achieve alone.”

The investment will reportedly allow Thorne to dramatically expand its US platform. The company adds that this investment paves the way for Thorne to broaden its reach in personalized health care by expanding into home testing platforms. Utilizing its large health care practitioner network, its research and content collaboration with Mayo Clinic, and its analytical software, Thorne’s goal is to become the market leader in bringing prevention and wellness into the homes of consumers in 2018.

“As a result of this investment, we expect to make several big key announcements over the next two months as we present a new platform to the marketplace,” added Paul Jacobson.

“We invested in Thorne’s supplement and testing platform because it meets the high-quality standards we set for ourselves in the heavily regulated Japanese market,” explained Masami Yokoyama, General Manager, NutriScience Division, at Mitsui. “As in other leading nations, the Japanese health care system is searching for ways to keep its population healthy through more natural approaches, so Thorne’s commitment to proving that its products work through testing and research make them the ideal partner for us.”

Thorne is a health and technology company that combines dietary and lifestyle recommendations with nutritional supplement intervention. It has a mission to help consumers take control of their own health and live a healthy life. Thorne provides at-home blood biomarker tests ‘to bring the doctor to the consumer’s home’. By leveraging its analytical software, Thorne ‘helps consumers uncover health insights and confidently take action to optimize healthier outcomes.’

Based on individual test results, Thorne’s technology and team can deliver a personalized plan on what to eat, how to exercise, and what Thorne supplements to take.

Thorne is the only supplement manufacturer to collaborate with Mayo Clinic on wellness research and content, and is the partner of a number of US national teams, including US Soccer, USA Hockey, USA Triathlon, and USA Rowing.

Mitsui is a diversified global trading, investment, and service enterprise, headquartered in Tokyo, Japan. Mitsui pursues ‘360° business innovation’, which ranges from product sales, worldwide logistics and financing, through to the development of major international infrastructure and other projects. It maintains a global network of 137 offices in 65 countries/regions, and has 462 group companies and associated companies worldwide.

www.thorne.com

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.